These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 35397395

  • 21. RNF130 protects against pulmonary fibrosis through suppressing aerobic glycolysis by mediating c-myc ubiquitination.
    Zhang J, Chen W, Du J, Chu L, Zhou Z, Zhong W, Liu D, Huang H, Huang Y, Qiao Y, Meng X, Zou F, Cai S, Dong H.
    Int Immunopharmacol; 2023 Apr; 117():109985. PubMed ID: 36893517
    [Abstract] [Full Text] [Related]

  • 22. Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.
    Huang LS, Fu P, Patel P, Harijith A, Sun T, Zhao Y, Garcia JG, Chun J, Natarajan V.
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):912-22. PubMed ID: 23808384
    [Abstract] [Full Text] [Related]

  • 23. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
    Nie Y, Zhang D, Qian F, Wu Y.
    Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
    [Abstract] [Full Text] [Related]

  • 24. Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis.
    Ruzehaji N, Frantz C, Ponsoye M, Avouac J, Pezet S, Guilbert T, Luccarini JM, Broqua P, Junien JL, Allanore Y.
    Ann Rheum Dis; 2016 Dec; 75(12):2175-2183. PubMed ID: 26961294
    [Abstract] [Full Text] [Related]

  • 25. Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway.
    Miao Y, Li X, Yang Y, Zhang J, Chen L, Zhang Q, Li W, Liu Y, Zhang X, Gu R, Yang C.
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109427. PubMed ID: 36375321
    [Abstract] [Full Text] [Related]

  • 26. PEDF is an antifibrosis factor that inhibits the activation of fibroblasts in a bleomycin-induced pulmonary fibrosis rat model.
    Qin X, Jia C, Liang J, Chen J, Liu X, Chao Z, Qin H, Yuan Y, Liu Z, Zhang Z, Dong H, Zhang H.
    Respir Res; 2022 Apr 22; 23(1):100. PubMed ID: 35459189
    [Abstract] [Full Text] [Related]

  • 27. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S, Zhuang Y, Shan B, Danchuk S, Luo F, Korfei M, Guenther A, Lasky JA.
    PLoS One; 2017 Apr 22; 12(10):e0186615. PubMed ID: 29045477
    [Abstract] [Full Text] [Related]

  • 28. Fenbendazole Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Suppression of Fibroblast-to-Myofibroblast Differentiation.
    Wang L, Xu K, Wang N, Ding L, Zhao W, Wan R, Zhao W, Guo X, Pan X, Yang J, Rosas I, Yu G.
    Int J Mol Sci; 2022 Nov 15; 23(22):. PubMed ID: 36430565
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice.
    Guo J, Fang Y, Jiang F, Li L, Zhou H, Xu X, Ning W.
    Eur J Pharmacol; 2019 Dec 01; 864():172712. PubMed ID: 31586469
    [Abstract] [Full Text] [Related]

  • 32. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression.
    Li Y, Sun Y, Wu N, Ma H.
    Am J Physiol Cell Physiol; 2022 Jan 01; 322(1):C63-C72. PubMed ID: 34852209
    [Abstract] [Full Text] [Related]

  • 33. The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway.
    Aydin P, Aksakalli-Magden ZB, Civelek MS, Karabulut-Uzuncakmak S, Mokhtare B, Ozkaraca M, Alper F, Halici Z.
    Adv Med Sci; 2023 Sep 01; 68(2):322-331. PubMed ID: 37716182
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF, Barron G, Meliton A, Mutlu GM, Dulin NO, Schuger L.
    Am J Respir Cell Mol Biol; 2019 Feb 01; 60(2):221-231. PubMed ID: 30230348
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK, Li XH, Wang W, Liu J, Zhang W, Fang YS, Zhang ZF, Dai HP, Ning W, Wang C.
    Chin Med J (Engl); 2018 Aug 20; 131(16):1917-1925. PubMed ID: 30082522
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.
    Hennuyer N, Duplan I, Paquet C, Vanhoutte J, Woitrain E, Touche V, Colin S, Vallez E, Lestavel S, Lefebvre P, Staels B.
    Atherosclerosis; 2016 Jun 20; 249():200-8. PubMed ID: 27108950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.